Ashland has put a new US$1b share repurchase plan on the table, doubling its prior authorization as management leans into cost savings and portfolio pruning to support margins and free cash flow. The buyback news comes as Ashland's share price has slipped 5.24% over the past 30 days, though the stock's year-to-date share price return of 16.57% and 1-year total shareholder return of 38.46% point to momentum building around the cost savings and buyback story. Ashland's most followed valuation narrative pegs fair value at $80.18 against a last close of $69.77, a roughly 13% discount, while a separate earnings-based view flags the stock's P/E of 42.6x against a fair ratio of 26.6x, a US Chemicals sector average of 23.2x, and a peer group closer to 20.7x. The company's specialty chemicals portfolio is positioned around high-value, sustainable, and compliant solutions, which is expected to support top-line revenue growth and margin resilience over the long term. The story could still break if demand softness in key export markets keeps squeezing Specialty Additives, or if portfolio pruning leaves growth and earnings more fragile than expected.
Ashland Global Holdings IncAshland unveiled a new US$1b share buyback, doubling its prior authorization, a financial/valuation event.
OK Rusal MKPAO